as on November 28, 2025 at 4:01 pm IST
Day's Low
Day's High
1.88%
Downside
1.65%
Upside
52 Week's Low
52 Week's High
31.12%
Downside
20.56%
Upside
as on November 28, 2025 at 4:01 pm IST
Market Cap
₹421.30 Cr
Return on Equity (ROE)
11.45
PE Ratio (TTM)
22.53
Return on capital employed (ROCE)
13.69
Industry PE ratio
42.13
Beta (LTM)
0.9
P/B Ratio
1.66
Dividend Yield
0.14
PEG Ratio
-2.14
Quarterly Earnings Growth YOY
94.85
EPS (TTM)
61.96
Sector
Pharmaceuticals
Book Value
650.15
Technical Analysis
Bullish
View Technical Analysis
as on November 28, 2025 at 4:01 pm IST
Haleos Labs Limited in the last 5 years
Lowest (3.76x)
October 16, 2019
Today (22.53x)
November 28, 2025
Industry (42.13x)
November 28, 2025
Highest (41.84x)
January 4, 2024
Today’s Price to Earnings Ratio: 22.53x
Compare market cap, revenue, PE, and other key metrics of Haleos Labs Limited with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 421.30 | 27.99% | 0.68 | 18 | 344 | |
| NA | 3,289.00 | 15.96% | 0.58 | 137 | 2,110 | |
| BUY | 4,110.18 | 6.53% | 0.63 | 128 | 1,243 | |
| NA | 20,067.78 | 37.9% | 0.68 | -57 | 3,012 | |
| NA | 360.31 | -12.21% | 0.67 | -3 | 133 |
Search interest for Haleos Labs Limited Stock has increased by 317% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:317% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Haleos Labs Limited.
Haleos Labs Limited’s net profit jumped 30.62% since last year same period to ₹6.10Cr in the Q2 2025-2026. On a quarterly growth basis, Haleos Labs Limited has generated 46.63% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2025, Haleos Labs Limited has declared dividend of ₹1.50 per share on 29 May 2025 - translating a dividend yield of 0.11%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 1 month, HALEOSLABS stock has moved up by 21.7%
Retail Holding Up
![]()
Retail Investor have increased holdings from 28.56% to 28.57% in Sep 2025 quarter
Best in 1 Year
![]()
In the last 1 year, HALEOSLABS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Profit Spike
![]()
Netprofit is up for the last 3 quarters, 2.97 Cr → 6.1 Cr (in ₹), with an average increase of 30.2% per quarter
Against Peers
![]()
In the last 3 years, Torrent Pharmaceuticals Ltd has given 127.6% return, outperforming this stock by 14.9%
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 71.41% of holdings in Sep 2025 quarter
Revenue Fall
![]()
Revenue is down for the last 3 quarters, 91.45 Cr → 81.79 Cr (in ₹), with an average decrease of 5.4% per quarter
FII Holding Down
![]()
Foreign Institutions have decreased holdings from 0.03% to 0.00% in Sep 2025 quarter
| Organisation | Haleos Labs Limited |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Haleos Labs Limited share price today stands at ₹1393.5 as on at the close of the market. Haleos Labs Limited share today touched a day high of ₹1416.5 and a low of ₹1367.3.
Haleos Labs Limited touched a 52 week high of ₹1680 and a 52 week low of ₹959.8. Haleos Labs Limited share price today i.e. is closed at ₹1393.5, which is -17.05% down from its 52 week high and 45.19% up from its 52 week low.
Haleos Labs Limited market capitalisation is ₹421.30 Cr as on .
To buy Haleos Labs Limited shares, you need to follow these steps:
Haleos Labs Limited trading volume is 2,131.00 as on . This means that 2,131.00 shares of Haleos Labs Limited were bought and sold on the stock market during today's trading session.